Every morning, in kitchens across America, a familiar ritual plays out: a hand reaches into a cupboard, shakes out a small tablet, and swallows it down with coffee or water. The multivitamin. For roughly one in three U.S. adults, according to the National Institutes of Health, this daily pill is a fixture of life — a tiny, affordable insurance policy against disease, decline, and an early grave.

The marketing around it hums with the same promise. “Supports” immunity. “Supports” energy. “Supports” heart health, brain health, longevity itself. Step into any drugstore and the bottles practically vibrate with wellness. The implication, sometimes stated outright in wellness podcasts and supplement ads, is straightforward: take this pill every day and you will live longer and dodge the big killers — heart disease and cancer.

It is a seductive claim, and it has survived for half a century. But in the last fifteen years, some of the largest nutrition studies ever conducted have put it to the test in tens of thousands of randomized volunteers and hundreds of thousands of observed people. The verdict of that evidence is remarkably consistent, and it is not what the bottle suggests. A daily multivitamin does not extend your life. It does not, for most people, prevent heart disease or cancer. The one finding that keeps the industry hopeful — a hint that multis may slightly slow cognitive aging in older adults — is real but modest, and it does nothing to rescue the longevity claim.

This is a classic Misleading claim: it takes a grain of truth (vitamins fix deficiencies; there are narrow groups who genuinely need them) and stretches it into a universal promise that the science does not support.

A colorful salad bowl — nutrition scientists say food, not a pill, is where the vast majority of people should get their vitamins. (Illustrative photo)

The Claim, Stated Plainly

The claim under review comes in several flavors, from the gentle to the grandiose:

• Gentle: “A daily multivitamin is a sensible insurance policy for your health.”
• Moderate: “Multivitamins help prevent heart disease and cancer.”
• Grandiose: “Take a multivitamin every day and you’ll live longer.”

The gentle version is arguable and partly defensible. It is the moderate and grandiose versions — disease prevention and longer life — that show up in advertising copy, influencer routines, and the hopes of the roughly one in three adults who take these products daily. The National Cancer Institute’s own framing puts the motivation bluntly: one in three U.S. adults uses multivitamins, “with a primary motivation being disease prevention.”

That is the claim we are testing: does a daily multivitamin prevent major disease and extend life?

Trial One: The Doctors’ Study (Physicians’ Health Study II)

The single best test ever run on this question is the Physicians’ Health Study II, or PHS II. Beginning in 1997, researchers at Harvard Medical School and Brigham and Women’s Hospital enrolled 14,641 male U.S. physicians aged 50 and older — average age 64 — and randomized them to a daily multivitamin or a dummy pill. Neither the doctors nor the researchers knew who got which. They were followed for a median of 11.2 years, with pill-taking compliance remaining high throughout.

This is the gold standard: a large, long, randomized, double-blind, placebo-controlled trial. And its headline results, published in the Journal of the American Medical Association in 2012, were a split decision that the supplement industry still quotes — selectively.

On cancer: the multivitamin group had about an 8 percent lower rate of total cancer (17.0 versus 18.3 cases per 1,000 men per year), a statistically significant reduction. Remove prostate cancer — the most common cancer in the group, and one unaffected by the pill — and the reduction rose to 12 percent. There was also a consistent, if not quite statistically significant, 12 percent reduction in dying from cancer.

On heart disease: nothing. Over eleven years, there was no significant effect of the daily multivitamin on major cardiovascular events — no reduction in heart attacks, no reduction in strokes, no reduction in cardiovascular death. There were slightly fewer total deaths in the multivitamin group (1,345 versus 1,412), but the difference was not statistically significant — indistinguishable from chance.

A later secondary analysis dug deeper, asking whether the pill might help people with worse diets, where a nutritional gap would be most plausible. Even there, across eleven years of follow-up, multivitamin use did not reduce the risk of major cardiovascular events, nonfatal heart attack, nonfatal stroke, or cardiovascular death.

So the landmark trial found a modest cancer signal — real, but small — and no cardiovascular benefit and no significant mortality benefit. In a room of well-nourished physicians, the pill moved the needle on one disease category slightly and on everything else not at all. And notably, the trial’s own investigators cautioned that their results may not extend to people with marginal intakes of vitamins — the very people you’d most expect to benefit.

Trial Two: The Women’s Study (Iowa Women’s Health Study)

If PHS II was a cautious maybe on cancer, the 2011 Iowa Women’s Health Study sounded an alarm — or at least, it was read that way in the headlines. Researchers at the University of Minnesota, led by Jaakko Mursu, followed 38,722 older women (average age about 62 at enrollment in 1986) for roughly two decades, tracking their use of fifteen different supplements and their survival.

The result was startling: women who reported taking multivitamins had a 6 percent higher risk of dying during follow-up than non-users. Supplemental iron showed the strongest association with increased mortality; folic acid, vitamin B6, magnesium, zinc, and copper were also linked to higher death rates. Only calcium was associated with living longer. The authors concluded there was “little justification for the general and widespread use of dietary supplements” and recommended they be used only for a strong medical reason, “such as symptomatic nutrient deficiency disease.”

But there is a crucial caveat, and it illustrates why observational studies are a rung below randomized trials. The Iowa study did not assign women to take pills or not — it simply observed that women who happened to take multivitamins died slightly sooner. It is entirely possible the arrow runs the other way: people who feel unwell reach for vitamins. The researchers tried to adjust for this, and reported they found no clear evidence that illness was driving the pattern — but the “healthy user” effect (or its reverse) is notoriously hard to wash out of observational data.

The study should not be read as proof that multivitamins kill. What it does show, powerfully, is the absence of any survival advantage in a population of nearly 39,000 women tracked for decades. If the pill extended life, this is the kind of study where the signal would appear. It did not.

Trial Three: COSMOS — The Big One (COcoa Supplement and Multivitamin Outcomes Study)

The largest and most ambitious trial of multivitamins ever conducted is COSMOS, led by JoAnn Manson at Brigham and Women’s Hospital. Between 2015 and 2022, COSMOS enrolled 21,442 U.S. adults aged 60 and older in a 2×2 factorial design testing cocoa extract and a daily multivitamin-mineral supplement against placebo, with a median follow-up of 3.6 years, targeting cardiovascular disease and cancer prevention.

On the headline chronic-disease outcomes, the multivitamin arm of COSMOS delivered no good news for the longevity claim. The trial found no reduction in invasive cancer, no reduction in cardiovascular events, and no mortality benefit from the daily multivitamin.

But COSMOS had cognitive substudies — and there, unexpectedly, the multivitamin did something. Three separate placebo-controlled substudies, using different cognitive tests on non-overlapping groups of participants, all pointed the same way:

• COSMOS-Mind tested about 2,200 older adults for three years with telephone-based cognitive assessments and found the multivitamin was associated with roughly a 60 percent slowing of global cognitive aging compared with placebo — equivalent to about 1.8 years less cognitive decline.
• COSMOS-Web tested around 3,500 participants with internet-based batteries and found improved immediate memory recall (the multivitamin group remembered about 0.71 words more on a 20-word list, versus 0.44 more in the placebo group).
• COSMOS-Clinic gave 573 participants in-person neuropsychological exams over two years and found a modest benefit on global cognition and episodic memory.

A 2024 meta-analysis pooling the three substudies — more than 5,200 non-overlapping participants — found what the authors called “clear evidence” of multivitamin benefits on global cognition and episodic memory, with an effect magnitude “equivalent to reducing cognitive aging by two years.” Manson called the pattern “exciting,” saying the finding “further supports the promise of multivitamins as a safe, accessible, and affordable approach to protecting cognitive health in older adults.”

This is the strongest genuine benefit ever demonstrated for multivitamins — and it deserves honesty about its size. The absolute effects were small: fractions of a standard deviation, less than a word’s worth of extra recall. The study populations were older, well-educated, and not representative of all Americans, and the researchers themselves noted that the specific nutrients responsible remain unidentified. A modest nudge to memory in older adults is a real finding, but it is a long way from “extends your life.”

The COSMOS trial’s cognitive substudies found that a daily multivitamin modestly slowed cognitive aging in adults over 60 — a real but small effect. (Illustrative photo)

The 2024 Study That Asked the Question Most Directly

In June 2024, the most direct test of the longevity claim landed in JAMA Network Open, from researchers at the National Cancer Institute. Erikka Loftfield and colleagues pooled three large prospective cohorts — the NIH-AARP Diet and Health Study, the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, and the Agricultural Health Study — for a combined 390,124 generally healthy U.S. adults, followed for more than 20 years, with up to 27 years of follow-up and 164,762 deaths recorded.

The analysis was designed specifically to defeat the biases that plague supplement research: people who take vitamins tend to live healthier lives generally (the healthy-user effect), and sick people sometimes start taking vitamins (reverse causation). The researchers adjusted for sex, age, race and ethnicity, education, smoking, body mass index, physical activity, alcohol and coffee intake, diet quality, and family history of cancer.

The result: daily multivitamin use was not associated with a mortality benefit. People who took a daily multivitamin had no lower risk of death from any cause — and no lower risk of death from cancer, heart disease, or cerebrovascular disease — than people who took none. The study’s own stated “Meaning”: “These findings suggest that multivitamin use to improve longevity is not supported.”

That is about as flat a rejection of the longevity claim as epidemiology can produce. Nearly 400,000 people, decades of follow-up, careful bias control — and the pill did nothing for lifespan.

And this was not an isolated result. A 2013 meta-analysis of 21 randomized controlled trials covering more than 90,000 people found no influence of multivitamins on mortality in either direction. The U.S. Preventive Services Task Force, the nation’s top independent prevention panel, reviewed the evidence in 2022 and issued an “I statement” for multivitamins: insufficient evidence to determine the balance of benefits and harms for preventing cardiovascular disease or cancer. In the same statement, the task force went further on two specific ingredients — recommending against beta-carotene and vitamin E supplements (a D recommendation), because beta-carotene increases lung cancer risk in smokers and those exposed to asbestos, and vitamin E shows no mortality benefit.

What Multivitamins Do and Don’t Do

Pulling the trials together, a clear picture emerges:

What they don’t do. They don’t extend life — the 2024 NCI analysis of 390,124 people says so plainly. They don’t prevent heart disease or stroke — PHS II and COSMOS say so. They don’t reliably prevent cancer — PHS II found a modest 8 percent reduction in total cancer in older male physicians, but COSMOS found no cancer reduction, and the USPSTF found the overall evidence insufficient.

What they might do. In older adults, they may modestly slow cognitive decline — the COSMOS substudies are genuinely promising, though the effects are small and the populations were narrow. In PHS II, they slightly reduced total cancer diagnoses in men over 50. They reliably correct deficiencies in people who have them — which is what they were designed for, back when vitamin deficiencies like scurvy and pellagra were real public-health threats.

What they can do wrong. High doses of specific nutrients carry documented risks. Beta-carotene raises lung cancer risk in smokers. Excess vitamin A can damage the liver and harm a developing fetus. Iron supplementation was linked to the highest mortality association in the Iowa study, and there is a strong dose-dependent pattern there worth respecting. A standard daily multivitamin is not a megadose product, but “more is better” is a dangerous instinct with micronutrients — the same molecules that heal at the right dose can harm at the wrong one.

There is also the subtler harm of misplaced confidence: the person who pops a multivitamin and considers the health box checked, while skipping the things that actually move the needle — not smoking, moving daily, eating vegetables, controlling blood pressure. Supplements are, as one researcher put it, a distraction from the message that stays simple: chronic disease is largely prevented by lifestyle.

Who Might Actually Benefit

None of the above means vitamins are useless. It means they are misused as a universal tonic when they are really a targeted tool. The evidence carves out clear exceptions:

Pregnant women and those who might become pregnant. Folic acid — a B vitamin — prevents neural tube defects, and prenatal vitamins are one of the most evidence-backed supplement uses in medicine. As Manson noted in her commentary on the USPSTF statement, “It’s important for women in pregnancy to take a prenatal vitamin and extra folic acid to prevent neural tube defects.”

People with diagnosed deficiencies. If bloodwork shows you are low in vitamin D, vitamin B12, or iron, supplementation is treatment, not wellness theater. Older adults are prone to B12 deficiency (including pernicious anemia), which responds to targeted B12.

People with restricted diets or absorption problems. Vegans and vegetarians may need B12; people with Crohn’s disease, celiac disease, prior bariatric surgery, or other malabsorption conditions can genuinely need supplementation at any age.

Older adults with specific needs. Vitamin D and calcium support bone health in the elderly; a specific antioxidant formulation slows age-related macular degeneration. And if the COSMOS cognitive findings hold up in further research, older adults hoping to protect memory are the one general population with a plausible, evidence-adjacent reason to consider a daily multi — while understanding the benefit is small.

People with poor diets. The irony of the multivitamin market is that the people most likely to benefit — those with genuine nutritional gaps — are often not the health-conscious, well-fed, college-educated consumers who buy the most pills. The PHS II physicians were, by definition, affluent and well-nourished; even so, the trial’s authors noted their findings might not apply to people with marginal intakes. The vitamin industry has built a $50-billion-plus global business selling gap-fillers to people without gaps.

Doctors and prevention experts recommend treating supplements as targeted medicine for real deficiencies — not as blanket insurance for everyone. (Illustrative photo)

Why the Myth Persists

If the evidence is this one-sided, why does the claim survive — and why do an estimated 78 percent of American adults now take at least one supplement, in a global market valued above $200 billion?

Part of the answer is regulatory. In the United States, supplements are governed by the 1994 Dietary Supplement Health and Education Act, which lets products reach shelves without proving they work. Labels can say a product “supports” immunity or energy — vague “structure/function” claims — without FDA pre-approval, as long as they don’t claim to treat a disease. The language is engineered to sound like science while promising nothing testable.

Part of the answer is psychological. The multivitamin is cheap, harmless-feeling, and effortless — a $10-a-month ritual that buys the sensation of having done something for your health. Researchers call this the “health halo”: one virtuous-seeming act that quietly licenses neglect elsewhere. And because vitamins genuinely cured deficiency diseases in the early 20th century, the leap from “vitamins cure scurvy” to “vitamins prevent everything” feels like common sense, even though decades of trials have failed to validate it.

And part of the answer is the industry’s selective memory. The 8 percent cancer reduction in PHS II gets quoted in marketing materials; the null results on heart disease, stroke, and death from the same trial do not. The COSMOS cognition findings get press releases; the COSMOS null results on cancer and cardiovascular disease get silence. Each new study is mined for the one flattering line and the rest is discarded.

The Verdict: Misleading

Verdict: Misleading.

The claim that taking a daily multivitamin extends your life or prevents major disease misrepresents what three decades of evidence actually shows.

On longevity — the boldest version of the claim — the answer is no. The 2024 National Cancer Institute analysis of 390,124 adults followed for over 20 years found daily multivitamin use was not associated with lower mortality from any cause, with the authors concluding that “multivitamin use to improve longevity is not supported.” A 2013 meta-analysis of 21 randomized trials in 90,000 people found no mortality effect either way.

On major-disease prevention, the evidence is thin to nonexistent. The best trial ever run (Physicians’ Health Study II, 14,641 men, 11+ years) found no reduction in heart attacks, strokes, or cardiovascular death — only a modest 8 percent dip in total cancer. The biggest trial ever run (COSMOS, 21,442 adults) found no cancer or cardiovascular benefit. The nation’s top prevention panel, the USPSTF, looked at all of it in 2022 and concluded there is insufficient evidence to recommend multivitamins for preventing cardiovascular disease or cancer.

The claim isn’t entirely false — that is what makes it Misleading rather than False. Multivitamins genuinely treat deficiencies; folic acid prevents birth defects; vitamin D and calcium protect bones; and the COSMOS cognitive substudies offer a real, if modest, memory signal in older adults. But “contains a grain of truth” is not the same as “true.” The promise sold to tens of millions of healthy adults — that a daily pill buys extra years and fends off the big killers — is not supported by the evidence.

No pill has been shown to add years to a healthy adult’s life — the daily habits that do are free. (Illustrative photo)

The Bottom Line

So should you keep taking your multivitamin? If you are pregnant, deficient, elderly with specific needs, or living with a malabsorption condition — yes, and talk to your doctor about exactly which nutrients you need, because a targeted supplement beats a scattershot multi. If you are a healthy adult eating reasonably well and taking it “for longevity” — the evidence says you are buying an expensive habit, not extra years. A standard multi is unlikely to hurt you, but as the Iowa study’s lead author Jaakko Mursu told Reuters: “There is very little evidence showing that common dietary supplements would be beneficial in prevention of major chronic diseases” — and “unless you are deficient, there is hardly any reason to take them.”

The most reliable life-extenders remain stubbornly unglamorous and unpatentable: don’t smoke, move every day, eat mostly plants, sleep enough, keep your blood pressure down, and see your doctor. No bottle on the drugstore shelf has ever beaten that list in a randomized trial — and after 400,000 studied lives, it is time we stopped pretending one will.

Before starting or stopping any supplement, the evidence-based move is the same: ask a clinician about your actual nutritional needs. (Illustrative photo)